A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique
Clinical trial NCT01697007 · COMPLETED
Trial details
- NCT number
- NCT01697007
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-12-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.